SciBase Holding AB (publ) (SCIB.ST) Research

SciBase Holding AB (publ), a medical technology firm founded in 1998 and headquartered in Sundbyberg, Sweden, specializes in the global development and distribution of instruments for diagnosing skin cancer and other dermatological issues. Their key offerings, Nevisense and Nevisense Go, comprise a point-of-care platform designed for the detection of melanoma and non-melanoma skin cancers, as well as for evaluating skin barrier function. The company also maintains a collaborative agreement with the Advanced Dermatology and Cosmetic Surgery (ADCS) group.

Market snapshot

Symbol
SCIB.ST
Price
$35.80
Day change
-15.47%
Market cap
$366.1M
P/E ratio
-1.71x
52-week range
16.66667-54
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months

Peer companies

  • Arcoma AB (ARCOMA.ST)
  • Biovica International AB (publ) (BIOVIC-B.ST)
  • Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST)
  • Scandinavian Real Heart AB (Publ) (HEART.ST)
  • Iconovo AB (publ) (ICO.ST)
  • Immunovia AB (publ) (IMMNOV.ST)
  • Luxbright AB (publ) (LXB.ST)
  • Nanologica AB (publ) (NICA.ST)

Open SciBase Holding AB (publ) (SCIB.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.